Adparkins Pharmaceuticals Private Limited
About Adparkins Pharmaceuticals Private Limited
Data last updated:
Adparkins Pharmaceuticals Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 21 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2016PTC288752.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Bagal Digambar Abasaheb and Anita Digambar Bagal.
Its last annual general meeting (AGM) was held on 24 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office is at Cts No. 15738/13 Shope No. 2 Varun Complex Basement Floor Ulka Nagari, Aurangabad, Maharashtra, India – 431001.
As per the financials filed for FY 2018, the company reported a revenue of ₹4.61 Lakh. For the same year it recorded a net profit of ₹3,310 (net margin 0.7%) and EBITDA of ₹8,210 (EBITDA margin 1.8%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Adparkins Pharmaceuticals Private Limited's registered office is in Aurangabad, Maharashtra.
- Registered AddressCts No. 15738/13 Shope No. 2 Varun Complex Basement Floor Ulka Nagari, Aurangabad, Maharashtra, India – 431001
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Adparkins Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Adparkins Pharmaceuticals Private Limited, buy the company report.
Financials of Adparkins Pharmaceuticals Private Limited
FY 2018 filings availableAdparkins Pharmaceuticals Private Limited reported revenue of ₹4.61 Lakh for FY 2018.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹8,210 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹3,310 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 1.8% | |
| Net Profit Margin | 0.7% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Adparkins Pharmaceuticals Private Limited, buy the company report.
Board of directors of Adparkins Pharmaceuticals Private Limited
Adparkins Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bagal Digambar Abasaheb | Director | 21 Dec 2016 | 9 Years 10 Months | Current |
| Anita Digambar Bagal | Director | 21 Dec 2016 | 9 Years 10 Months | Current |
Peer comparison
Adparkins Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Oagwin Pharmaceuticals Private Limited | ₹4.66 Lakh (FY 2025) | -14.0% | Chennai, Tamil Nadu, India | |||
| Adparkins Pharmaceuticals Private Limitedthis company | ₹4.61 Lakh (FY 2018) | ₹3,310 | 0.7% | Aurangabad, Maharashtra, India | ||
| Medoc Pharmaceuticals Private Limited | ₹4.58 Lakh (FY 2024) | -12.0% | Delhi, India | |||
| Steadymed Pharmaceuticals Private Limited | ₹4.58 Lakh (FY 2023) | -22.0% | Kolkata, West Bengal, India | |||
| Neurolife Pharmaceuticals Private Limited | ₹4.58 Lakh (FY 2020) | 131.0% | Palampur, Himachal Pradesh, India |
To see the full peer comparison of Adparkins Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Adparkins Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Adparkins Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Adparkins Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Adparkins Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Anita Digambar Bagal was appointed as Director on 21 Dec 2016.
Frequently asked questions
Adparkins Pharmaceuticals is an active private limited company based in Aurangabad, Maharashtra, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 21 December 2016 (10+ years old) and is registered under CIN U74999MH2016PTC288752.
Adparkins Pharmaceuticals has 2 current directors:
- Bagal Digambar Abasaheb - Director
- Anita Digambar Bagal - Director
The latest financial statements of Adparkins Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 24 September 2018. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of Adparkins Pharmaceuticals is U74999MH2016PTC288752. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Adparkins Pharmaceuticals was incorporated on 21 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Adparkins Pharmaceuticals by revenue are Oagwin Pharmaceuticals Private Limited, Medoc Pharmaceuticals Private Limited, Steadymed Pharmaceuticals Private Limited, Neurolife Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Anita Digambar Bagal was appointed as Director on 21 Dec 2016. Bagal Digambar Abasaheb was appointed as Director on 21 Dec 2016.
The registered office of Adparkins Pharmaceuticals is at Cts No. 1573813 Shope No. 2 Varun Complex Basement Floor Ulka Nagari, Aurangabad, Maharashtra, India – 431001.
Adparkins Pharmaceuticals operates in the business services industry, in the miscellaneous business activities segment.
The compliance status of Adparkins Pharmaceuticals is compliant as of 18 August 2026. The company is actively filing with the Registrar of Companies.
Adparkins Pharmaceuticals can be reached at its registered office: Cts No. 1573813 Shope No. 2 Varun Complex Basement Floor Ulka Nagari, Aurangabad, Maharashtra, India – 431001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
